In this age of massive genetic and protein information, a fast and reliable method of studying in vivo proteinprotein interactions is necessary. We have developed a novel system that can overcome limitations of existing assay methods. This new method adopts two existing systems for fast analysis of diverse proteinprotein interactions. For rapid, large-scale cloning, we adopted the Gateway system and developed novel destination vectors containing YFP N-terminus (YN) or YFP C-terminus (YC) to visualize protein-protein interactions in vivo using bimolecular fluorescence complementation (BiFC). Using this system, we investigated molecular interactions among the three POZ-domain regulatory proteins mAPM-1, LRF, KLHL10 that belong to a subgroup of human POZdomain proteins, and showed that the POZ-domains of mAPM-1, LRF and KLHL10 could form both homodimers and heterodimers. This new method is
Introduction
Cells carry out diverse biological functions through complex protein-protein interactions. Comprehensive determination of protein-protein interactions is important because it provides a framework for understanding both biological regulation through protein-protein interaction and the functional roles of many regulatory gene products. Various methodologies for analyzing protein-protein interactions have been developed; however, they have several limitations when studying large numbers of protein-protein interactions.
Most existing interaction assay methods have limitations with respect to cloning and protein expression. Cloning of genes is a time-consuming process and expression of functionally active recombinant proteins in a heterologous host, such as Escherichia coli or Saccharomyces cerevisiae, is often difficult. In vitro protein-protein assays, such as affinity chromatography, a highly efficient, sensitive and specific assay method for protein-protein interaction in vivo.
pull-down assay, and protein chip can generate falsepositive signal by electrostatic interactions, although in vitro protein-protein assay is often required [1, 2] .
The yeast two-hybrid system is widely used as in vivo assay method [3] . However, if the interacting proteins are corepressor, repressor or contain a repressor domain, the interaction will not activate transcription and expression of the nutrition marker genes, and the molecular interaction can not be detected although the proteins interact with each other [4, 5] . Detection of weak interactions can also be difficult because of poor growth of yeast. Immunoprecipitation, another popular in vivo protein-protein interaction assay, requires highly specific antibodies that are often not available, and non-specific aggregations or precipitates can generate false-positive results [1, 2] . To overcome these problems, we developed an assay method which takes advantage of the Gateway system and bimolecular fluorescence complementation (BiFC) assay system.
The Gateway system enables convenient and efficient cloning of many genes into various vectors without restriction endonucleases and ligase treatment [6, 7] . The recently developed techniques of BiFC enable visualization of direct protein-protein interaction in intact cell. The BiFC assay is based on fluorescence generated by reconstitution of non-fluorescent molecules when they are brought together by specific interaction of fused proteins [8, 9] .
The BTB/POZ (broad complex, tramtrack and brica-brac/poxvirus and zinc finger) domain is an evolutionarily conserved protein-protein interaction domain that is found at the N-terminus of many cellular regulators important in transcription, signal transduction, development, differentiation and oncogenesis [10] [11] [12] [13] [14] [15] . Although some POZ-domain proteins are known to interact with other POZ-domains and non-POZ-domain proteins such as PLZF, Bcl-6, mSin3A, SMRT, N-CoR, HDAC, Sp1, and Cullin3 ubiquitin liagse [5, [15] [16] [17] [18] , their interaction partnerships and function of the interactions are largely unknown.
Using the new protein-protein interaction assay system, we analyzed the protein-protein interactions among the POZ-domain subgroup composed of mAPM-1 [19] , LRF [20] and KLHL10 [21] and demonstrated that the POZ-domains formed both homodimers and heterodimers in vivo. The assay system is a highly efficient and sensitive compared with conventional protein-protein assay methods, and we were able to analyze the in vivo protein-protein interactions among the POZ-domains in 2-3 days.
Materials and Methods

Construction of plasmids pFPIA-YN, YC, and various pFPIA-POZ-YN or pFPIA-POZ-YC protein-protein interaction assay plasmids
pBiFC-YN, pBiFC-YC, pBiFC Jun-YN and pBiFC Fos-YC were kindly provided by Dr. Kerppola (University of Michigan, MI, USA). The reading frame A (RA) cassette (Invitrogen, CA, USA) was inserted into pBiFC-YFP N-terminus (a.a. 1-154, HindIII-EcoRV) and pBiFC-YFP C-terminus (a.a. 155-238, EcoRIXhoI). We introduced cDNA fragments encoding nuclear localization signal of SV40 large T antigen (NLS, a.a PPKKRKV) [22] were introduced into the N-terminus of the above two vectors. FLAG Tag (a.a. YPYDVPDYA) and HA Tag (a.a. DYFLDDDK) were introduced into the C-terminus of YN and YC, respectively. The pFPIA system has new linker (YN, DPAFLYKVVISVPVDSRGSRSIAT; YC, DPAFLYKVVMISRGTAAARPACKIPNDLKQKVMNH) added downstream of NLS and in front of DNA region encoding YN or YC. Oligonucleotide primers used for PCR from BiFC-YN and BiFC-YC are as follows: pFPIA-YN forward, 5´-GAT CCT CGA GAC CAT GGC TCC TCC AAA AAA GAA G AGA AAG GTA CTT GCG GCC GCG AAT TCA-3´; pFPIA-YN reverse, 5´-GAT CGG GCC CTC ACT TGT CGT CAT CGT CTT TGT AGT CGG CCA TGA TAT AGA CGT T-3´; pFPIA-YC forward, 5´-GAT CAA GTT ACC ATG GCT CCT CCA AAA AAG AAG AGA AAG GTA CTT ATG GCC ATG GAG GCC-3´; pFPIA-YC reverse, 5´-GAT CTC TAG ATC AAG CGT AAT CTG GAA CAT CGT ATG GGT ACT TGTAC AGC TCG TCC AT-3´. Purified NLS-RA-YN-FLAG and NLS-RA-YC-HA PCR products were cloned into pcDNA3.0 using XhoI-ApaI and HindIII-XbaI to generate pFPIA(NLS)-YN and pFPIA(NLS)-YC, respectively. The pFPIA(NLS)Δ(Cm (forward, 5´-GGG GAC AAG TTT GTA CAA  AAA AGC AGG CTA CCC AGC TTT CTT GTA CAA AGT GGT  CCC C-3´; reverse, 5´-GGG GAC CAC TTT GTA CAA GAA  AGC TGG GTA GCC TGC TTT TTT GTA CAA ACT TGT CCC  C-3´ with CGT GGA CGG C-3´; reverse 5´-GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC CTG CCG GTC CAG GAG-3´. KLHL10 POZ-domain expression clone, forward 5´-GGG GAC AAG TTT GTA CAA AAA AGC AGG CTC TGA GAG CAC CGC-3´; reverse 5´-GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC ACA CAG CTC CGA CTT GAG-3´. The entry clones were generated by BP reaction using attR flanked POZ-doman PCR products and pDONR221 (Invitrogen, CA, USA). The entry clone was selected based on kanamycin resistance (positive selection) and loss of chloramphenicol resistance (negative selection). Because chloramphenicol resistance gene in the donor vector was replaced with the gene of interest by recombination, it was removed as by-product. The loss of chloramphenicol resistance was confirmed by growth test on a chloramphenicol LB agar plate and used as a negative selection marker. After positive and negative selection, selected entry clones were used for the preparation of mammalian POZ-domain expression clones by LR reaction. The expression clone was positively selected by ampicillin resistance and negatively by chloramphenicol resistance. The POZ-domains were located between NLS and YN or YC, and the YN and YC had C-terminal FLAG or HA tags, respectively. All BP reaction and LR reaction were performed according to manufacturer's protocol using BP clonase TM Enzyme Mix and LR clonase TM Enzyme Mix (Gateway system, Invitrogen, CA, USA).
For mammalian two-hybrid assays, PCR amplified cDNA fragments encoding POZ mAPM-1 , POZ LRF , and POZ KLHL10 , were cloned into pCMX-Gal4 and pCMX-VP16 plasmids.
To prepare recombinant GST-fused POZ mAPM-1 and POZ KLHL10 , PCR amplified cDNA fragments were cloned into pGEX4T1 (Amersham Biosciences, NJ, USA) plasmid. pGEX4T3-POZ LRF plasmid was previously described [17] . All plasmid constructs were verified by sequencing.
Analysis of amino acid sequences homology of human BTB/POZ domain proteins
Amino acid sequences of virtually all POZ-domains were obtained from the BTB/POZ-domain database (http:// xtal.uhnres.utoronto.ca/prive/btb.html) and analyzed by MacVector 7.2 Clustal W alignment program (Accelrys, CA, USA). The multiple alignment results were used to construct a phylogenetic tree based on distances between each pair of sequences by successive clustering (data not shown). Divergences of each base pair or evolutionary distance from multiple alignment results were calculated, and a phylogenetic tree was constructed using the Neighbor-Joining method. Evolutionary distances were calculated by uncorrected pdistance.
Cell culture and mammalian two-hybrid assays
African green monkey kidney cells (CV-1) were grown in Dulbeco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum and 100 units/ml streptomycin and penicillin (Invitrogen, CA, USA). Cells were plated into 6-well tissue culture plates. After the cells had grown for 12 hrs, they were transiently transfected with the pCMX-Gal4-POZdomain (0.4 µg), VP16-POZ-domains plasmid (0.4 µg), pG5-Luc (0.2 µg) and pCMV-lacZ (0.2 µg) using Lipofectamine Plus TM reagent (Invitrogen, CA, USA) in OPTI-MEM (Invitrogen, CA, USA). After 3 hrs, the cells were supplied with DMEM-10% FBS and allowed to grow for additional 12 hrs. Cells were harvested and lysed in 1x reporter lysis buffer (Promega, WI, USA). Luciferase reporter assays were performed using luciferase assay reagent (Promega, WI, USA) on a luminometer (EG&G Berthold, Germany). Luciferase activities were normalized with β-galactosidase activity and the protein concentration of the cell extracts was determined by the Bradford method. The assays were repeated at least three times.
Analysis of protein-protein interactions in vivo
CV-1 cells were maintained as described above. Cells grown on a glass-bottom dish (MatTek coporation, MA, USA) were cotransfected with a total of 1.2 µg of YN (0.6 µg) and YC (0.6 µg) fused protein expression plasmids using Lipofectamine Plus TM reagent (Invitrogen, CA, USA). Fluorescence was determined after 24 hrs. All fluorescent image analysis of cells transfected with YFP-POZ-domain expression plasmids was performed using LSD 510 confocal microscope (Carl Zeiss, Germany).
In vitro protein-protein interaction assay
pGEX4T3POZ LRF, and pGEX4T1POZ KLHL10 expression plasmids were transformed into E. coli BL21 (DE3). To prepare recombinant GST-POZ-domain fusion proteins, E. coli BL21 (DE3) was induced to express the fusion proteins by incubating for 4 hrs with 0.5 mM IPTG (isopropyl-1-thio-β-D-galactopyranoside) at 37°C. The harvested E. coli were resuspended in HEMG buffer (40 mM HEPES, pH7.9; 100 mM KCl, 0.2 mM EDTA, 5 mM MgCl 2 , 0.1% Nonidet P-40, 10% glycerol, 1.5 mM dithiothreitol) supplemented with 1 tablet/50 ml of a protease inhibitor mixture (Roche, Germany) and lysed by sonication. The supernatant of the lysate was applied onto a Glutathione-agarose 4B bead affinity column (Peptron round mutagenesis, YC forward, 5´-AAA GAA GAG AAA GGT AAT TAT GGC CAT GGA GGC CC-3´; YC reverse, 5´-GGG CCT CCA TGG CCA TAA TTA CCT TTC TCT TCT TT-3´. The first mutagenesis changed ACCATG of NLS to ACCTTG, and second mutagenesis changed AGAAAG to AGAATG in YNfusion expression constructs and CTTATG to ATTATG in YCfusion constructs. After two round of mutagenesis, the translation start codon ATG is located downstream of disrupted NLS. The PCR mixture has 1 µl of Ultra PFU Taq-polymerase (Stratagene, CA, USA), 5 µl of 10x Ultra PFU Taq buffer, 100 ng of plasmid template, 125 ng of sense and anti-sense oligonuceotide primers and 4 µl of dNTPs (2.5 mM). PCR cycling conditions were as follows: 94°C for 30 sec and 18 cycles of 94°C for 30 sec, 55°C for 1 min, 68°C for 8 min, and final extension reaction at 68°C for 10 min. After finishing the PCR, 20 µl of the samples are digested with DpnI at 37°C for 1 hr and 10 µl of the samples were transformed into E. coli DB3.1 to prepare mutated YN or YC fusion expression constructs plasmids.
Results
New protein-protein interaction assay plasmid vectors, pFPIA-YN and pFPIA-YC
We generated a new plasmid set that enables high speed cloning and visualization of protein-protein interactions in vivo based on the Gateway system and BiFC (Fig. 1) . These plasmids were designated pFPIA: plasmids for fast protein-protein interaction assay. They commonly had a NLS, reading frame A, and FLAG or HA tags. The reading frame A contains attR sites, the ccdB gene and chloramphenicol resistance gene. High speed cloning is possible through att sites-specific recombination without treatment with restriction enzymes and DNA ligase. The ccdB gene products inhibit E. coli DNA gyrase and inhibit growth of most E. coli strains such as DH5α [23] . By BP and LR recombination reactions, while genes of interest were cloned into donor and destination vectors, ccdB and chloramphenicol genes were removed from the donor and destination vectors as by-products of recombination reactions. To ensure transfer of gene in each reaction, kanamycin resitance (for entry clone) or ampicillin resistance (for expression clone) is used as a positive selection marker and chloramphenicol resistance is used as a negative selection marker.
These positive and negative selection markers contribute to higher cloning efficiency of genes of interest [6] . Attachment of a NLS at the N-terminus was considered because detection of weak protein-protein interaction in whole cell could be difficult. Targeted expression of proteins in the nucleus could make the protein-protein interaction assay more sensitive. FLAG or HA-tags were used to monitor expression of two interacting proteins.
The POZ-domain is a highly conserved proteinprotein interaction motif found in many regulatory proteins.
POZ-domain proteins are involved in many critical cellular processes through interaction with each other and with other regulatory proteins [10, 15] . The domain can form homomeric and heteromeric associations with other POZdomains. Because most proteins play different roles depending on their partnerships, elucidation of complex protein-protein interaction network among the POZdomain proteins may be crucial in understanding biological functions of the POZ-domain class proteins. Analysis of the amino acid sequence of virtually all of the human POZ-domains using ClustalW program of Macvector 7.2 revealed that they were classified into 31 subgroups. We selected a subgroup that contains mAPM-1 (mouse homolog of human APM-1, Genbank accession no. BC070424) [19] , LRF (leukemia/lymphoma-related factor, ortholog of human FBI-1, Genbank accession no. AF086830) [20] and KLHL10 (mouse homolog of human KL10, Genbank accession no. AY495337) [21] . Analysis of structural features based on amino acid sequences showed that these proteins commonly have the POZ-domains at their N-terminal. LRF and mAPM-1 have four very similar zinc fingers, while KLHL10 has six kelch motifs ( Fig. 2A) . Amino acid sequence similarity among POZ mAPM-1 , POZ LRF , and POZ KLHL10 is 49-70%, suggesting the possibility of molecular interactions (Fig. 2B-D) . We investigated the protein-protein interactions of these POZ-domains for validation of our high speed BiFC protein-protein interaction assay. And the specific molecular interaction between Jun and Fos and YFP fluorescence by molecular interaction between Jun and Fos were well documented [9] .
Visualization of molecular protein-protein interactions among BTB/POZ domains in living cells
The POZ-domains of mAPM-1, LRF and KLHL10 interacted as homodimers and heterodimers, however interactions involving KLHL10 were weak (Fig. 3A, B) . Because fluorescence is generated by the molecular interaction, the intensity could depend on which part of YFP (YN or YC) was fused with which POZ-domain. We therefore fused the POZ-domains with alternative YFP fragments and observed fluorescence of similar intensity (data not shown). Western blotting assay with FLAG and HA antibodies showed that pFPIA(NLS)Δ(Cm R -ccdB)-YN and pFPIA(NLS) Δ(Cm R -ccdB)-YC were expressed in the cells (Fig. 3C) . Expression of POZ-domains was also analyzed by western blot.
Based on the crystal structures of several POZdomains, others have previously shown that α1, β1, B1, B2 and A1 parts of POZ-domain are important in dimeric interaction [14] . To provide negative controls for the interaction assay, we prepared several POZ-domain expression plasmids with deletions at the regions critical for molecular interaction. YN or YC fused with the POZdomain with this deletion did not give fluorescence, suggesting that mutated POZ-domains did not interact with other POZ-domain partners (Fig. 4) .
Investigation of interaction using mammalian twohybrid assay
Mammalian two-hybrid assay is frequently used to study protein-protein interactions in transfected cells. We examined whether the POZ-domain interaction data obtained by our newly developed method are in agreement with the mammalian two-hybrid assay. GAL4-and VP16-fused POZ mAPM-1 , POZ LRF , POZ KLHL10 were prepared, and cotransfected into CV-1 cells in various combinations to detect molecular interaction among the POZ-domains. POZ mAPM-1 and POZ LRF interacted and could form both homodimers and heterodimers, consistent with the data obtained by FPIA system (Fig. 5A) . However, POZ KLHL10 did not show homodimeric and heterodimeric interactions. It appears that the molecular interactions involving KLHL10 may be too weak to give transcriptional activation. This may be due to low sensitivity of the mammalian two-hybrid assay methods compared with the developed FPIA system. Because the mammalian two- hybrid assay is based on expression of a reporter gene, weak molecular interactions may not give sufficient transcriptional activation (reviewed in 21 and reference 12 there in). In addition, molecular interactions involving transcription repressors such as some POZ-domains cannot efficiently activate transcription of the reporter gene and can be difficult to detect.
Investigation of direct interactions among the POZ-domains by in vitro GST-pull down assay
To substantiate that the molecular interaction revealed by the FPIA system is generated by direct protein-protein interactions, we carried out GST-fusion protein pull-down assays. Recombinant GST, various GST-POZ-domains, and [ 35 S]-methionine labeled POZdomain polypeptides were prepared and mixed in various combinations to investigate the molecular interaction among the POZ-domains. Pulldown of the GST-fusion protein-agarose complexes and SDS-PAGE/ autoradiography analysis of the precipitates showed that the POZ mAPM-1 formed homodimers and also interacted with POZ LRF and POZ KLHL10 , whereas the recombinant GST used as a negative control did not interact (Fig. 5B) . The pull-down assay clearly shows direct protein-protein interactions among the POZ-domains of this particular subgroup that were not apparent in the mammalian two-hybrid assay but were detected by the FPIA assay. Overall, the newly developed FPIA method is fast, reliable, and sensitive. This assay can provide reliable proteinprotein interaction information in vivo in just 3 days. (Fig. 6A) . Our data suggest that the new pFPIA plasmid system can be used to investigate molecular interactions not only in nucleus but also in cytoplasm. Therefore, by selecting appropriate expression pFPIA plasmid set depending on the need of investigator, one can analyzed the protein-protein interaction between proteins of interest in their normal physiological environment.
Protein-protein interaction between the POZ LRF proteins with no NLS attached in cytoplasm and nucleus
Discussion
The molecular mechanisms underlying biological processes can be best understood by dissecting the molecular network of protein-protein interactions. With the completion of the human genome project, there is an ever-increasing need for highly efficient in vivo proteinprotein interaction assay methods to investigate gene function. Several methods have been developed to analyze protein-protein interaction, but due to their technical nature most of these have some limitations with respect to efficient large-scale detection of protein-protein interactions in living cells [1] [2] [24] [25] . Most methods require purified functionally active proteins and antibodies. Cloning the gene of interest can take several days and protein expression in a soluble form, purification, correct folding and translational modifications are often very difficult, if not impossible [1, 2] . In addition, in vitro protein-protein interactions have to be confirmed by in vivo assays because the proteins removed from their normal physiological condition can behave differently from the native forms. In vivo approaches, especially yeast two-hybrid assay, are widely used to screen protein-protein interactions. However, interactions that dependent on a posttranslational modification that does not occur in yeast will not be detected [1] [2] 23] . Moreover, molecular interactions that lead to transcriptional repression or weak transcription activation cannot be detected and 30-50% false positive results were reported [4] [5] [24] [25] . Immunoprecipitation is one of the widely used in vivo protein-protein interaction assay. However, since target proteins have to be precipitated by antibodies, this method requires highly specific antibodies that are not always available, and experimental artifacts exist due to nonspecific bindings of various proteins to antibodies that might never occur in vivo [1] . Finally, while the information gained from proteome-wide interaction maps is highly valuable, the generation of interaction map is time-consuming and requires extensive labor. In addition, assay results have to be confirmed by in vivo assay methodologies.
For these reasons, we developed an efficient in vivo protein-protein interaction assay system by adopting the Gateway system and BiFC. The power of the Gateway system is that BP and LR recombination mediated cloning can be performed within 6 hrs in a eppendorf tube and a high percentage (>95%) of the transformed E. coli contain the desired clone along with the ccdB gene and chloramphenicol resistance gene that act as negative and positive selection markers, respectively [6, 27] . In addition, once genes of interest are selected, they can be transfected and subcloned into several other vectors at a time using an in vitro recombination reaction [6] .
Our system also adopted BiFC to analyze proteinprotein interactions in living cells. BiFC analysis does not require any information on the proteins and can be useful in studying any protein-protein interaction in vivo. By using standard fluorescence or confocal microscopy, interactions can be analyzed easily and staining of the cells with exogenous fluorescent molecules or dyes is not required [9, 28] .
One limitation of BiFC is intrinsic association of fluorescence YFP fragments without specific interaction between proteins [28] . It is therefore necessary to confirm specificity of protein-protein interactions using mutant proteins with critical mutations in the protein-protein interaction interface [9, 28] . The generation of mutant proteins for all interesting proteins is time-consuming and not easy if the important interface to protein-protein interaction is unknown. Fortunately, in the FPIA system we developed, molecular interaction by spontaneous association of YN and YC was not detected. The possibility of false-positives due to forced nuclear expression of the YFP fusions was examined by mutant POZ-domains. The FPIA system therefore does not require generation of mutant protein for each protein of interest.
Compared with other protein-protein interaction assays, such as mammalian two-hybrid assay and GST pull-down assay, our FPIA assay method is very sensitive and highly efficient in detecting even weak protein-protein interaction. The major advantages of the FPIA assay system is that protein-protein interaction can be examined in 3 days from gene cloning to interaction study (Fig. 7) . This assay system requires only 3 steps: preparation of target DNA fragment with att sites at both 5' and 3' ends by PCR (2-3 hrs), BP and LR reaction mediated cloning into pDONR, pFPIA(NLS)-YN and pFPIA(NLS)-YC (6 hrs), transient transfection into cells (12 hrs), and finally microscopic observation.
Moreover, our new system can be applied to screen a cDNA library made with pFPIA(NLS)-YN or YC to isolate cDNAs encoding proteins that interact with the protein of interest. Firstly, one has to establish a stable cell line expressing YN or YC fused with the protein of interest. A cDNA library prepared in one of the pFPIA plasmids is transfected into these cells, and one simply needs to isolate cells that give fluorescence. After amplification of such cells, the corresponding cDNA can be isolated by PCR and sequenced.
The FPIA method may be one of the powerful methods available to investigate protein-protein interaction of structurally diverse proteins in many different cell types and organisms in normal physiological context.
